• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Microbiol . Novel Use of Rapid Antigen Influenza Testing in the Outpatient Setting as an Early Warning Sign of Influenza Activity in the Eme

tetano

Editor, Senior Moderator
J Clin Microbiol


. 2020 Sep 23;JCM.01560-20.
doi: 10.1128/JCM.01560-20. Online ahead of print.
Novel Use of Rapid Antigen Influenza Testing in the Outpatient Setting as an Early Warning Sign of Influenza Activity in the Emergency Departments of an Integrated Health System


Paige M K Larkin[SUP] 1 [/SUP], Vladimir Manuel[SUP] 2 [/SUP], Naureen Hernandez[SUP] 1 [/SUP], Omai B Garner[SUP] 3 [/SUP]



Affiliations

Abstract

Seasonal influenza virus is associated with high morbidity and mortality especially in vulnerable patient populations. Here we demonstrate the novel use of Sofia Influenza A + B FIA, a rapid antigen-based influenza point-of-care test (POCT), combined with Virena software for automatic de-identified tracking of influenza activity across the Los Angeles area and for predicting surges of influenza cases in the emergency department (ED). We divided outpatient clinics into 6 geographic zones and compared weekly influenza activity. In the outpatient setting, there were 1,666 and 274 influenza A and influenza B positives, respectively, across the 2018-2019 influenza season and 1,857 and 1,449 influenza A and influenza B positives, respectively, during the 2019-2020 influenza season, with zone-specific differences observed. Moreover, we found that a rapid increase in outpatient influenza was followed by an influx in influenza positive cases in the ED, offering a 1-3 week warning sign for ED influx of triple or quadruple the number of influenza cases compared to the prior week. Sofia Influenza A + B FIA allows for surveillance of real-time deidentified influenza activity. Tracking of such data may serve as a valuable region-specific influenza indicator and predictor to guide infection prevention measures in both the outpatient and hospital settings. High impact interventions include designating areas of waiting rooms for influenza-like illnesses, altering staff scheduling in anticipation of surges, and securing sufficient personal protective equipment and antivirals during the height of influenza season.
 
Back
Top Bottom